RXRalpha: a novel target for prostate cancer

Cancer Biol Ther. 2003 Mar-Apr;2(2):185-6.

Authors

Krishan K Pandey¹, Surinder K Batra

Affiliation

¹ Department of Biochemistry and Molecular Biology, The Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska 58198-4525, USA.

PMID: 12750560

No abstract available

Publication types

Comment
Editorial

MeSH terms

Animals
Apoptosis / drug effects
Cell Division / drug effects
Epithelial Cells / metabolism
Epithelial Cells / pathology
Gene Expression Regulation, Neoplastic
Humans
Male
Mice
Prostate / pathology
Prostatic Hyperplasia / genetics
Prostatic Hyperplasia / metabolism*
Prostatic Hyperplasia / pathology
Prostatic Neoplasms / genetics
Prostatic Neoplasms / metabolism*
Prostatic Neoplasms / pathology
Receptors, Retinoic Acid / genetics
Receptors, Retinoic Acid / metabolism*
Retinoid X Receptors
Transcription Factors / genetics
Transcription Factors / metabolism*
Transcription Factors / pharmacology

Substances

Receptors, Retinoic Acid
Retinoid X Receptors
Transcription Factors